to-BBB; drug delivery to the brain

to-BBB technologies BV

to-BBB is a Dutch biotechnology company in the field of enhanced drug delivery across the blood-brain barrier.

to-BBB’s vision is that the treatment of currently unserved brain diseases will be best achieved by safely enhancing the blood-to-brain delivery of drugs.

The company is developing novel treatments for devastating brain disorders by combining existing drugs with its proprietary brain delivery platform.

LATEST NEWS:

- to-BBB announces two additional pharma collaborations on brain drug delivery, January 7

- to-BBB and Lundbeck to join forces on brain delivery of antibodies for CNS diseases, December 22

- to-BBB announces collaboration with Genzyme on brain delivery of biologics for neurodegenerative diseases, November 03

- Corvitex and to-BBB join forces to raise funds in the USA, October 21

FACT SHEETS:

Please see the corporate factsheet and the G-Technology factsheet for an overview of to-BBB and its core technology platform.

LATEST PRESS RELEASE:

Download here our latest press release.

(photo: Aad van Vliet / TwoMoves)